Sirona Dx Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Sirona Dx's estimated annual revenue is currently $2M per year.(i)
  • Sirona Dx's estimated revenue per employee is $155,000

Employee Data

  • Sirona Dx has 13 Employees.(i)
  • Sirona Dx grew their employee count by -24% last year.

Sirona Dx's People

NameTitleEmail/Phone
1
Co-founder-CEOReveal Email/Phone
2
Chief Commercial OfficerReveal Email/Phone
3
Chief Commercial OfficerReveal Email/Phone
4
Director Program ManagementReveal Email/Phone
5
Laboratory DirectorReveal Email/Phone
6
Director Spatial BiologyReveal Email/Phone
7
Director Single-Cell ProteomicsReveal Email/Phone
8
Director Research DevelopmentReveal Email/Phone
9
Research ScientistReveal Email/Phone
10
Research Scientist/Data AnalystReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2M13-55%N/AN/A
#2
$22.9M14811%N/AN/A
#3
$7.4M489%N/AN/A
#4
$0.8M50%N/AN/A
#5
$39.9M206-2%N/AN/A
#6
$1.4M9-18%N/AN/A
#7
$2.8M186%N/AN/A
#8
$0.8M50%N/AN/A
#9
$9.1M5913%N/AN/A
#10
$0.9M620%N/AN/A
Add Company

What Is Sirona Dx?

Sirona Dx is a technical CRO, founded to accelerate the pace of targeted therapy development. Bridging silos between Dx manufacturers, translational clinical research, and clinical service labs we offer specialized high complexity genomics and proteomics services supporting pharmaceutical companies with their drug discovery and development programs. Sirona Dx operates a CLIA certified facility and collaborates with leading platform providers including ThermoFisher, illumina, Fluidigm and nanoString to secure early access to advanced technologies. We offer a comprehensive menu of high parameter IO expression profiling assays to explore tumor immunobiology and identify new biomarkers. We have embraced mass cytometry platforms from Fluidigm to support high parameter protein profiling assays of individual cells in suspension (Helios) as well as in tissues (Hyperion). We have leading expertise in the extraction of RNA from challenging sample types including FFPE enabling our pharma clients to profile more of their precious samples. Our experienced team offers expertise for clinical protocol design combined with a variety of customized reporting, clinical trial site training, and investigator support.

keywords:N/A

N/A

Total Funding

13

Number of Employees

$2M

Revenue (est)

-24%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.7M13-13%N/A
#2
$2.1M13-32%N/A
#3
$1M13N/AN/A
#4
$0.4M13-13%$9.4M
#5
$1.6M1318%N/A